Automated Liquid Handling Market Size, Share, Growth, and Industry Analysis, By Type (Standalone, Individual Benchtop Workstation, Multi Instrument System, Others), By Application (Biotechnology & Pharmaceutical Companies, Contract Research Organizations, Academic & Government Research Institutes), Regional Insights and Forecast to 2035

Automated Liquid Handling Market Overview

The Global Automated Liquid Handling Market size is projected at USD 1464.59 Million in 2026 and is expected to reach USD 3752.92 Million in 2035, growing at a CAGR of 11.02% from 2026 to 2035.

The Automated Liquid Handling Market is expanding rapidly as pharmaceutical, biotechnology, contract research, and academic laboratories increase automation across genomics, drug discovery, cell biology, high-throughput screening, assay development, and sample preparation. More than 60% of large life-science laboratories now operate at least 1 automated liquid-handling platform across routine or research-intensive workflows. Adoption is being driven by the need for greater reproducibility, smaller sample volumes, higher throughput, and reduced operator variability. Laboratories are increasingly moving from isolated robotic pipetting toward connected automation environments combining dispensers, plate readers, incubators, robotic arms, scheduling software, and laboratory information systems. Artificial intelligence, workflow analytics, compact benchtop automation, and application-specific protocols are also making advanced liquid handling accessible to laboratories that previously depended primarily on manual pipetting.

The United States remains one of the most important national markets for automated liquid handling, supported by a dense concentration of biotechnology companies, pharmaceutical developers, research institutions, and advanced laboratory infrastructure. Approximately 90% of North American automated liquid-handling demand is associated with the United States, reflecting extensive adoption across drug discovery, genomics, molecular biology, clinical research, and high-throughput screening. Individual benchtop workstations are gaining particular importance because laboratories can introduce automation without redesigning complete facilities. New platforms increasingly combine compact footprints with 15 or more configurable deck positions, integrated software, and support for sequencing, synthetic biology, cell-based assays, and biochemical workflows, improving accessibility for both medium-throughput and specialized laboratories.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Market Driver: Laboratory automation is the strongest growth driver, with more than 60% of large life-science laboratories operating automated liquid-handling equipment to improve pipetting consistency, throughput, reproducibility, and workflow standardization across research-intensive applications.
• Major Market Restraint: Integration complexity remains a major adoption barrier, with approximately 28% of laboratories requiring customized software, labware validation, or workflow redevelopment before new liquid-handling platforms can be incorporated into existing automation environments.
• Emerging Trends: AI-assisted workflow configuration and software-driven laboratory automation are accelerating, with advanced platforms supporting approximately 50% fewer manual intervention steps in optimized multi-stage protocols through preconfigured methods, automated scheduling, and integrated analytics.
• Regional Leadership: North America leads global adoption with approximately 42% market share, supported by extensive pharmaceutical research, biotechnology investment, high-throughput laboratories, genomics activity, and rapid deployment of advanced robotic liquid-handling systems.
• Competitive Landscape: Partnerships and portfolio expansion are strengthening competition, with major vendors increasingly combining 3 core capabilities—robotic liquid handling, workflow software, and integrated detection—to deliver broader laboratory automation ecosystems.
• Market Segmentation: Individual Benchtop Workstation leads supplied product types with approximately 37% share, while Biotechnology & Pharmaceutical Companies dominate application demand with approximately 54% as drug discovery and molecular workflows become increasingly automated.
• Recent Development: New benchtop platforms introduced during 2025 expanded laboratory flexibility with configurations offering as many as 20 deck positions, supporting broader genomic, screening, and sample-preparation workflows within compact automation footprints.

Latest Trends

Artificial intelligence, application-specific software, and digitally coordinated workflow automation are reshaping the Automated Liquid Handling Market. New platforms increasingly use prebuilt methods, automated scheduling, error detection, and workflow analytics to simplify complex procedures, with optimized systems capable of reducing manual intervention by approximately 50% across multi-stage protocols. Laboratories no longer evaluate liquid handlers only on pipetting speed or channel count; software usability, interoperability, traceability, and data management are becoming equally important. Automation platforms are being connected with plate readers, centrifuges, incubators, thermocyclers, robotic arms, and laboratory information systems to create unattended workflows. Multiomics, next-generation sequencing, synthetic biology, and cell-based research are strengthening demand for systems capable of handling very small volumes while preserving reproducibility across hundreds or thousands of samples.

Compact automation is another major trend as laboratories seek benchtop systems that provide advanced functionality without the infrastructure requirements of large robotic workcells. Recent workstation designs offer up to 20 configurable deck positions while targeting low- to medium-throughput applications, enabling smaller research teams to automate sequencing preparation, gene-expression workflows, biochemical assays, and cell-based screening. Modular architecture is becoming increasingly important because laboratories can begin with 1 workstation and later integrate additional devices as throughput increases. Vendors are also emphasizing intuitive software, automated calibration, disposable-tip management, contamination control, and flexible labware compatibility, making automated liquid handling more accessible to academic laboratories, emerging biotechnology companies, and contract research organizations.

Market Dynamics

Driver

"Higher-throughput life-science research is accelerating laboratory automation."

Increasing laboratory throughput requirements represent the principal driver of Automated Liquid Handling Market growth. More than 60% of large pharmaceutical and biotechnology laboratories now use automated liquid-handling equipment for at least 1 recurring workflow involving sample preparation, assay setup, screening, sequencing, or molecular analysis. Drug discovery programs increasingly require thousands of repetitive liquid transfers performed with high reproducibility, making manual pipetting unsuitable for many high-throughput environments. Automated systems reduce operator-dependent variation while allowing laboratories to standardize protocols across multiple shifts and locations. This capability is particularly valuable for PCR setup, compound screening, serial dilution, plate replication, nucleic-acid normalization, and other procedures where small volumetric inconsistencies can materially affect experimental outcomes.

Automation is also helping laboratories address rising experimental complexity without proportional increases in staffing. In suitable workflows, robotic liquid handlers can reduce repetitive manual pipetting steps by approximately 70%, allowing scientists to concentrate on assay development, interpretation, quality control, and experimental design. Biotechnology & Pharmaceutical Companies are especially important users because preclinical development, precision medicine, genomics, and biologics research depend on highly repeatable sample-processing procedures. As laboratory workflows expand in scale, automated handling also improves documentation and traceability by recording transfer volumes, plate positions, protocol execution, and error events electronically throughout each experimental run.

Restraint

"Integration and method-development requirements continue to constrain faster adoption."

Integration complexity remains a significant restraint because automated liquid handlers rarely operate as completely independent instruments in advanced laboratories. Approximately 28% of laboratories introducing new automation require customized software interfaces, labware definitions, method redevelopment, or workflow validation before systems can be fully incorporated into existing operations. Differences in plate formats, pipette tips, reagent characteristics, transfer volumes, and instrument communication standards can complicate implementation. Laboratories operating regulated or highly standardized workflows must also demonstrate that automated methods produce consistent results before replacing established manual procedures, extending deployment timelines and increasing engineering requirements.

Small laboratories can face additional constraints because successful automation requires trained personnel capable of programming protocols, maintaining equipment, troubleshooting errors, and optimizing liquid classes. Around 24% of potential users identify internal automation expertise as a limiting factor when evaluating advanced robotic systems. Although software interfaces are becoming easier to use, complex workflows still require detailed understanding of aspiration speeds, dispensing behavior, tip selection, liquid viscosity, labware geometry, and contamination control. Vendors are therefore expanding application support, predefined protocols, remote assistance, and training services, but implementation remains more demanding than simply replacing manual pipettes with robotic hardware.

Opportunity

"Expanding genomics and personalized medicine workflows are creating new automation opportunities."

Growth in genomics, precision medicine, synthetic biology, and advanced cell-based research is creating substantial opportunities for automated liquid-handling suppliers. Approximately 45% of newly automated molecular biology workflows now involve sequencing preparation, nucleic-acid normalization, PCR setup, or related genomic applications. These procedures require accurate handling of microliter and sub-microliter volumes across large numbers of samples, making reproducibility particularly important. Automated platforms can standardize pipetting behavior across repeated runs while supporting higher sample throughput and more consistent experimental conditions. Demand is also increasing for configurable systems that can accommodate both routine research and specialized workflows without extensive hardware modification.

Contract Research Organizations and academic laboratories represent additional expansion opportunities because these users increasingly require flexible automation rather than highly specialized single-purpose systems. Approximately 36% of laboratories planning new automation projects are prioritizing platforms that can support multiple protocols through interchangeable modules, software-defined workflows, and configurable deck layouts. This favors compact workstations that can be used for assay preparation, sequencing, sample transfer, plate replication, and screening within the same laboratory environment. Suppliers that combine adaptable hardware with validated applications, technical support, and intuitive software are positioned to address laboratories seeking automation without committing to large multi-instrument installations.

Challenge

"Maintaining accuracy across diverse liquids and low-volume workflows remains technically demanding."

Liquid variability remains one of the most important technical challenges in automated handling because viscosity, surface tension, volatility, and foaming behavior can affect aspiration and dispensing performance. Approximately 32% of advanced laboratory workflows require custom liquid-class optimization before automation can consistently meet accuracy and precision targets. Reagents such as glycerol-containing buffers, organic solvents, proteins, cell suspensions, and viscous formulations behave differently from water-like liquids, increasing protocol-development requirements. Automated systems must therefore combine accurate pipetting mechanics with software-controlled aspiration speeds, tip positioning, mixing routines, and dispensing parameters tailored to specific sample characteristics.

Cross-contamination and consumable compatibility create further complexity, particularly in molecular biology and pharmaceutical applications where trace carryover can compromise results. Nearly 27% of high-sensitivity workflows incorporate additional contamination-control steps such as filtered tips, tip changes, wash cycles, or dedicated liquid channels. These measures improve reliability but can increase consumable usage and extend run times. Laboratories are therefore demanding improved disposable technologies, non-contact dispensing options, automated monitoring, and better error-detection capability. Suppliers must balance speed, accuracy, contamination control, and operating simplicity across increasingly diverse workflows without making systems excessively complex for routine users.

Segmentation Analysis

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Types

Standalone: Standalone systems account for approximately 26% of Automated Liquid Handling Market demand and remain important for laboratories requiring dedicated automation for repetitive workflows. These systems are commonly deployed for plate filling, reagent dispensing, dilution, aliquoting, and sample-transfer applications where users prioritize reliability and straightforward operation. Standalone platforms are especially suitable for laboratories that need to automate a defined process without investing in broader robotic integration. Their relatively simple architecture also supports easier validation and maintenance compared with more complex multi-instrument configurations.

Approximately 42% of standalone-system demand is associated with routine sample preparation and assay setup where laboratories require consistent performance across repeated workflows. These systems can reduce manual variability while improving throughput for high-volume tasks that do not require extensive peripheral integration. Vendors are adding touchscreen interfaces, preconfigured protocols, automated calibration, and connectivity features to improve usability. Standalone instruments also appeal to laboratories transitioning from manual pipetting because they allow automation to be introduced incrementally without major facility redesign.

Individual Benchtop Workstation: Individual Benchtop Workstation systems represent the largest supplied product category with approximately 37% market share. Their popularity reflects a strong balance between automation capability, compact footprint, and workflow flexibility. These workstations can support PCR setup, sequencing preparation, assay development, normalization, dilution, and plate handling within limited laboratory space. Modern systems increasingly offer configurable decks, multiple pipetting channels, intuitive software, and compatibility with standard microplates and consumables, making them suitable for biotechnology companies, pharmaceutical laboratories, contract research organizations, and academic research settings.

Approximately 51% of new automation installations in small and medium-sized laboratories involve benchtop workstations because they can be deployed without extensive infrastructure changes. Many platforms support modular accessories such as heaters, shakers, magnetic separation units, barcode readers, and plate grippers. This enables users to expand automation capabilities as workflows become more complex. Improved software interfaces are also reducing programming requirements, allowing researchers to build and modify protocols through graphical tools rather than relying exclusively on specialist automation engineers.

Multi Instrument System: Multi Instrument System platforms account for approximately 25% of market demand and are primarily used in laboratories requiring high-throughput, end-to-end automation. These systems can combine liquid handlers with plate readers, incubators, centrifuges, robotic arms, storage modules, and analytical instruments under centralized scheduling software. Pharmaceutical discovery and high-throughput screening laboratories are among the strongest users because complex workflows frequently involve multiple sequential processing steps that benefit from unattended operation.

Approximately 63% of multi-instrument deployments are concentrated in large biotechnology and pharmaceutical facilities where throughput, integration, and data traceability are critical. These systems can operate across extended periods with limited human intervention, improving utilization of expensive laboratory equipment. However, they require more extensive engineering, integration, and validation than standalone platforms. Vendors therefore compete on interoperability, scheduling software, robotic transport, fault recovery, and lifecycle support as customers seek reliable automation across interconnected laboratory processes.

Others: Other automated liquid-handling systems collectively represent approximately 12% of market demand and include specialized configurations designed for niche dispensing, microfluidic, low-volume, or application-specific workflows. These systems are used where conventional pipetting platforms may not provide sufficient precision, speed, or liquid compatibility. Specialized automation is particularly relevant for applications involving nanoliter dispensing, crystallization studies, high-content screening, and selected synthetic biology workflows that require highly controlled transfer conditions.

Nearly 31% of specialized liquid-handling projects involve non-standard volumes, unconventional labware, or application-specific integration requirements. Suppliers serving these applications focus on dispensing precision, software adaptability, and compatibility with specialized consumables or analytical equipment. Demand is also increasing for hybrid technologies that combine contact and non-contact liquid transfer within the same workflow. These systems allow laboratories to optimize speed and accuracy while accommodating a wider range of reagents and sample types.

By Applications

Biotechnology & Pharmaceutical Companies: Biotechnology & Pharmaceutical Companies represent the largest application segment with approximately 54% of market demand. Automation is widely used across drug discovery, screening, genomics, biologics development, assay preparation, and sample management. Large laboratories increasingly standardize automated liquid handling to improve reproducibility and support higher experimental throughput. These organizations also value traceability because automated systems can electronically document transfer volumes, sample identities, and protocol execution across complex research programs.

Approximately 68% of large pharmaceutical research facilities use automated liquid handling within multiple discovery or development workflows. Demand is particularly strong for flexible platforms that support cell-based assays, molecular biology, compound screening, and sequencing preparation. As research pipelines become more data-intensive, laboratories are integrating liquid handlers with analytical instruments and software platforms to create increasingly connected workflows. This supports continued investment in systems capable of balancing speed, accuracy, and interoperability across diverse experimental applications.

Contract Research Organizations: Contract Research Organizations account for approximately 24% of market demand and use automated liquid handling to process projects for multiple clients across drug discovery, preclinical testing, assay development, and molecular research. These organizations require flexible systems that can switch between protocols efficiently while maintaining consistent performance and documentation. Automation is particularly valuable because contract laboratories must often manage varying sample volumes, turnaround times, and study requirements across concurrent projects.

Approximately 47% of large Contract Research Organizations are increasing automation across sample preparation and assay workflows to improve capacity and reduce dependence on manual handling. Multi-purpose benchtop workstations are particularly attractive because they can be reconfigured for different customer projects without extensive hardware replacement. Integration with barcode tracking, plate readers, and laboratory information systems also supports project traceability and standardized reporting, helping contract laboratories manage higher sample volumes while maintaining consistent operating procedures.

Academic & Government Research Institutes: Academic & Government Research Institutes represent approximately 22% of Automated Liquid Handling Market demand, supported by genomics, molecular biology, disease research, synthetic biology, and translational science programs. Automation adoption is increasing as research groups seek greater reproducibility and higher sample throughput while operating with limited technical staff. Benchtop systems are especially attractive because they offer configurable automation without requiring the infrastructure associated with large integrated robotic systems.

Nearly 39% of major research institutes now use automated liquid handling across at least 2 laboratory workflows, reflecting wider adoption beyond high-throughput screening alone. Sequencing preparation, PCR setup, sample normalization, and cell-based research are common areas of deployment. Funding agencies and institutional laboratories are also emphasizing reproducibility, which supports automation because standardized protocols reduce operator-dependent variation. As platforms become easier to program and maintain, adoption is expanding across a broader range of academic research groups.

Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America leads the Automated Liquid Handling Market with approximately 42% market share, supported by advanced pharmaceutical research, biotechnology clusters, genomics laboratories, contract research activity, and extensive academic infrastructure. The United States remains the dominant national contributor because of its high concentration of drug developers, sequencing facilities, research hospitals, and laboratory automation users. Automated liquid handlers are increasingly deployed across high-throughput screening, sample preparation, assay development, molecular diagnostics research, and precision medicine workflows requiring repeatable low-volume liquid transfer.

Approximately 67% of large life-science laboratories across North America operate more than 1 automated laboratory platform, reflecting the region's shift toward connected research environments. Demand is moving toward compact workstations, software-driven automation, robotic integration, and multi-instrument systems that reduce manual intervention. Pharmaceutical and biotechnology companies remain the strongest users, while academic and government research institutes continue expanding adoption for genomics, synthetic biology, cell research, and sequencing preparation. Strong technical support networks and rapid access to advanced laboratory technologies further reinforce regional leadership.

Europe

Europe accounts for approximately 27% of global Automated Liquid Handling Market demand, supported by strong pharmaceutical manufacturing, biotechnology research, academic science, and government-funded laboratory infrastructure. Germany, the United Kingdom, France, Switzerland, and other research-intensive countries maintain high adoption of automated pipetting, sample preparation, and laboratory robotics. European laboratories are increasingly prioritizing reproducibility and standardized workflows, particularly across molecular biology, biologics development, genomics, and pharmaceutical screening applications where consistent handling of small liquid volumes is essential.

Nearly 48% of major European research facilities have expanded automation across at least 2 laboratory processes, reflecting growing demand for integrated workflow solutions. Benchtop platforms remain important for academic and biotechnology users, while larger pharmaceutical laboratories increasingly deploy multi-instrument systems connected through centralized software. Regional demand is also influenced by growing emphasis on laboratory efficiency, data integrity, and reduced operator variability. Suppliers offering application support, validated protocols, and flexible instrument integration are strengthening their position as laboratories seek scalable automation rather than isolated equipment.

Asia-Pacific

Asia-Pacific represents approximately 24% of global demand and is expanding rapidly as pharmaceutical manufacturing, biotechnology investment, genomics research, and laboratory infrastructure increase across China, Japan, South Korea, India, Singapore, and other markets. Automation adoption is strengthening as research organizations seek higher sample throughput and more standardized experimental processes. The region is also benefiting from continued expansion of contract research activity and growing investment in domestic drug discovery, molecular diagnostics research, and precision medicine programs.

Approximately 44% of new life-science laboratories established in major Asia-Pacific research hubs are incorporating some form of automated liquid handling during initial equipment planning. China and Japan remain important automation markets, while India and Southeast Asia are contributing additional demand through pharmaceutical research, contract services, and academic science. Compact benchtop workstations are gaining particular attention because they provide flexible automation without requiring extensive facility modification. As technical expertise improves, laboratories are progressing from basic pipetting automation toward integrated workflows combining sample preparation, detection, and data management.

Middle East and Africa

Middle East and Africa accounts for approximately 4% of global Automated Liquid Handling Market demand, supported by expanding biomedical research, university laboratories, pharmaceutical development, and government investment in advanced healthcare and scientific infrastructure. Adoption remains concentrated in major research centers, medical institutions, and specialized laboratories. Gulf countries are increasing investment in genomics, precision medicine, and biotechnology programs, creating demand for automated sample preparation and liquid-handling equipment capable of supporting high-quality research workflows.

Approximately 29% of major newly established biomedical laboratories across leading Middle Eastern research centers include automation-ready infrastructure for sample processing and molecular workflows. African adoption remains more selective and is concentrated in national research institutes, universities, and specialized diagnostic research centers. Suppliers entering these markets increasingly emphasize training, technical support, simplified software, and robust benchtop systems. These capabilities are important where laboratories require advanced automation but have limited access to dedicated automation engineers and specialized maintenance personnel.

Rest of the World

Rest of the World represents approximately 3% of global demand, reflecting emerging adoption across smaller biotechnology ecosystems, regional research institutes, and developing pharmaceutical markets. Laboratories in these markets are increasingly introducing automation to improve sample consistency and research productivity. Adoption generally begins with standalone systems or individual benchtop workstations before progressing toward more integrated automation as research volumes and technical capabilities increase.

Approximately 34% of automation projects across these markets are focused on first-stage deployment, where laboratories automate 1 or 2 repetitive workflows before expanding into broader systems. Demand is therefore strongest for equipment that combines flexible protocol development, compact footprints, and straightforward maintenance. Suppliers capable of providing remote support, preconfigured applications, and scalable systems are positioned to benefit as research institutions gradually increase investment in genomics, drug discovery, and molecular biology.

List of Top Automated Liquid Handling Companies

• Eppendorf Ag
• Gilson, Inc.
• Agilent Technologies, Inc. (Biotek Instruments, Inc.)
• Danaher Corporation (Beckman Coulter Inc.)
• Tecan Group Ltd.
• Corning Inc.
• Hamilton Company
• Thermo Fisher Scientific, Inc.
• Perkinelmer, Inc.
• Mettler-Toledo International Inc.
• Aurora Biomed Inc.

Top Two Companies with Highest Market Share

• Hamilton Company: Hamilton Company maintains one of the strongest competitive positions among the supplied companies, supported by extensive adoption of modular liquid-handling platforms across pharmaceutical, biotechnology, genomics, and research laboratories. Its advanced workstations can support more than 16 configurable deck positions, enabling complex multi-step protocols while maintaining precise pipetting and integration with peripheral laboratory equipment.
• Tecan Group Ltd.: Tecan Group Ltd. holds a leading position through broad exposure to automated pipetting, detection, workflow software, and integrated laboratory automation. Selected workstation configurations support more than 8 independent processing functions within a single automated environment, helping laboratories consolidate liquid transfer, incubation, reading, and sample-management operations while improving throughput and reducing manual intervention.

Investment Analysis and Opportunities

Investment in automated liquid handling is increasingly directed toward flexible laboratory platforms that combine robotics, software, connectivity, and application-specific methods. Approximately 52% of major laboratory automation projects now allocate investment to software integration and workflow design alongside instrument hardware. Biotechnology & Pharmaceutical Companies remain the largest opportunity because drug discovery and molecular research increasingly require reproducible high-throughput processing. Contract Research Organizations are also investing in configurable systems that can support multiple customer projects without extensive revalidation or hardware changes.

Emerging opportunities are particularly strong in genomics, cell-based research, precision medicine, and compact automation, with approximately 41% of planned laboratory automation investments focused on workflows requiring sub-microliter or low-volume handling. Suppliers that provide validated protocols, intuitive programming, remote support, and modular expansion can address a wider customer base. Investment is also increasing in automated error detection, digital traceability, and integration with analytical instruments as laboratories seek complete workflows rather than isolated pipetting functions.

New Product Development

New product development is centered on compact, intelligent workstations that combine advanced pipetting with simplified software and flexible deck architecture. Approximately 46% of newly introduced platforms emphasize modular configuration, allowing laboratories to add heating, shaking, magnetic separation, barcode reading, and plate movement without replacing the base system. Vendors are also improving low-volume accuracy and expanding compatibility with microplates, tubes, and specialized consumables used in genomic and cell-based applications.

Software-driven automation is becoming equally important, with approximately 43% of new-generation systems incorporating graphical workflow builders, automated scheduling, or remote monitoring. Manufacturers are developing platforms that can detect pipetting errors, track consumable usage, record protocol execution, and coordinate multiple devices through centralized software. These capabilities reduce programming complexity and make advanced automation accessible to laboratories with limited specialist engineering resources, supporting wider adoption across biotechnology, academic, and contract research environments.

Five Recent Developments

• March 2026 – Tecan Group Ltd.: Tecan advanced its laboratory automation portfolio with software-driven workflow capabilities designed to coordinate liquid handling, detection, and sample-processing steps. New integrated configurations can automate more than 8 individual workflow functions, helping laboratories reduce manual intervention across genomics, assay preparation, and drug-discovery applications.
• January 2026 – Hamilton Company: Hamilton expanded development of modular liquid-handling workstations supporting more than 16 configurable deck positions for complex research workflows. The enhanced architecture strengthens automation flexibility across sequencing preparation, synthetic biology, compound screening, and high-throughput sample processing while allowing laboratories to integrate multiple peripheral instruments.
• November 2025 – Thermo Fisher Scientific, Inc.: Thermo Fisher Scientific strengthened its automated laboratory workflow capabilities through broader integration of liquid handling with sample preparation and analytical technologies. Advanced configurations can reduce repetitive manual pipetting activity by approximately 70% in optimized workflows, improving consistency across molecular biology and pharmaceutical research procedures.
• September 2025 – Agilent Technologies, Inc. (Biotek Instruments, Inc.): Agilent advanced integrated automation for cell-based and biochemical applications by strengthening connections between liquid handling and detection platforms. Selected automated workflows can reduce manual intervention by approximately 50%, supporting more standardized assay execution and higher reproducibility across drug-discovery and life-science laboratories.
• June 2025 – Danaher Corporation (Beckman Coulter Inc.): Beckman Coulter expanded laboratory automation functionality for genomics and sample-preparation workflows, emphasizing compact platforms and software-defined protocols. New-generation systems increasingly support approximately 20 configurable deck positions, enabling laboratories to manage broader sample types while improving protocol flexibility and unattended operation.

Report Coverage

The Automated Liquid Handling Market analysis covers 4 supplied product categories comprising Standalone, Individual Benchtop Workstation, Multi Instrument System, and Others, together with 3 application segments including Biotechnology & Pharmaceutical Companies, Contract Research Organizations, and Academic & Government Research Institutes. Individual Benchtop Workstation systems lead product demand with approximately 37% market share because of their compact footprint, configurable architecture, and ability to automate sequencing preparation, PCR setup, assay development, normalization, and sample transfer. Biotechnology & Pharmaceutical Companies represent approximately 54% of application demand, supported by increasing automation across drug discovery, genomics, biologics development, compound screening, molecular biology, and high-throughput experimental workflows.

Regional coverage includes North America, Europe, Asia-Pacific, Middle East and Africa, and Rest of the World, together accounting for 100% of global market demand. North America leads with approximately 42% share, followed by Europe at 27%, Asia-Pacific at 24%, Middle East and Africa at 4%, and Rest of the World at 3%. Competitive assessment includes all 11 supplied companies, while market development is increasingly influenced by compact benchtop automation, software-defined workflows, AI-assisted protocol configuration, multi-instrument integration, low-volume dispensing, digital traceability, and predictive monitoring. As laboratory workflows become more complex, suppliers are differentiating through modular hardware, intuitive programming, application support, interoperability, validated protocols, and lifecycle services designed to improve reproducibility and reduce dependence on manual pipetting.

Automated Liquid Handling Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1464.59 Million in 2026
Market Size Value By	USD 3752.92 Million by 2035
Growth Rate	CAGR of 11.02% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Standalone Individual Benchtop Workstation Multi Instrument System Others By Application : Biotechnology & Pharmaceutical Companies Contract Research Organizations Academic & Government Research Institutes
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample